DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Yamazaki N, Takenouchi T, Fujimoto M. et al.
Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041).
Cancer Chemother Pharmacol 2017;
79: 651-660
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.